Sanofi Consumer Healthcare India Limited · NSE:SANOFICONR
Sanofi Consumer Healthcare India — Investor Presentation (March 2026)
28 slides from Sanofi Consumer Healthcare India's investor presentation, Mar 24, 2026
Slide 1: Exchange filing cover letter for investor presentation
24th March 2026 The Secretary The Secretary BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, C-1, Block G, Exchange Plaza, Dalal Street, Bandra-Kurla Complex, Mumbai - 400 001 Bandra East, Mumbai - 400 051 Scrip Code: 544250 Symbol: SANOFICONR Sub.: Investor Presentati
Slide 2: Sanofi Consumer Healthcare Investor Meet
SANOFI CONSUMER HEALTHCARE Investor Meet 24th March 2026
Slide 3: Re-igniting Profitable Growth
Re-igniting Profitable Growth Himanshu Bakshi Managing Director
Slide 4: Safe Harbor Statement
Safe Harbor Statement This Release / Communication, except for the historical information, may contain statements, including the words or phrases such as ‘expects, anticipates, intends, will, would, undertakes, aims, estimates, contemplates, seeks to, objective, goal, projects, should’ and similar e
Slide 5: Agenda
Agenda Journey since inception Road Ahead Our Strategy 4
Slide 6: Agenda: Journey since inception
Agenda Journey since inception Road Ahead Our Strategy 5
Slide 7: Sanofi Consumer Healthcare: Snapshot
Sanofi Consumer Healthcare: Snapshot Revenue from operations Profit from operations ROCE Leading Brands ₹ 8784 Mn 36.7% 62.5% Avil # 1 vol Allegra # 3 val Combiflam # 5 vol DePura # 5# FY 2025 Data # Pre Recall Source : IQVIA MAT Dec’25 Includes AI-generated images
Slide 8: Case for separation: Play in Consumer Healthcare by its rules
Case for separation : Play in Consumer Healthcare by its rules Pharma Approach Consumer Healthcare Approach Win with patented formulations Win on Brand Equity Prescription driven Synergy of Prescriptions & Self choice Off Patent brands fund New Launches Sustained investments in brand building Diseas
Slide 9: Turbulent start for an organization still taking shape
Turbulent start for an organization still taking shape • Investments curtailed Demerger Successful Combiflam Allegra DePURA Manpower Voluntary New identity DePURA 60k into a sperate listing at the suspension suspension Kids re- • Nutra biz rationalization Recalls & workplace relaunch entity exchange
Slide 10: Starting point – constrained demand generation
Starting point – constrained demand generation Health Care Point of Professionals Consumer Sale – – – Includes AI-generated images
Slide 11: We have unlocked demand levers after a long gap
We have unlocked demand levers after a long gap Health Care Point of Professionals Consumer Sale – – – Includes AI-generated images
Slide 12: Put together a team that Makes It Happen
Put together a team that Makes It Happen + Attracted Best in class FMCH Talent + Performance driven Culture + Recognised as Most Preferred Workplace – Overall & Women + Wellness at core of workplace & policies
Slide 13: Leading to strong business performance
Leading to strong business performance +21% +13% +33% Revenue Operating Profit After from Profit Tax operations vs FY 2024 Includes AI-generated images
Slide 14: And did our bit for healthier planet and society
And did our bit for healthier planet and society PROJECT AMRIT VAN MITRA B CORP CERTIFICATION Our B Corp Certification. Certifying highest standards of verified social and environmental performance, public transparency, and legal accountability to balance profit and purpose 36 Water Community Center
Slide 15: Agenda: Road Ahead
Agenda Journey since inception Road Ahead Our Strategy 14
Slide 16: Significant growth opportunities exist within our core categories
Significant growth opportunities exist within our core categories High headroom for Significant growth upside through share gains category penetration ALLERGY ₹ 9399 Cr ~3/10 suffered from Allergy in last 6 months ₹ 5241 Cr PAIN ₹ 1469 Cr ~9/10 experienced a Pain episode 2.4% 9.0% 1.8% VIT D Pain
Slide 17: Our Strength
® whoever invented Combiflam, plea them a Nobel, no? Our Strength e is Avil. Yes thank you, have to get my d supplements soon. ura 60k for a coupla months and u r god to for a ye:
Slide 18: Consumers taking health in hands – time is ripe for self care
Consumers taking health in hands – time is ripe for self care Source of Trial Pain 53 Mn Indians accessing health Allergy related info online Doctor Reccomended Self Select 26% consumers Influencers important drivers of self-medicating brand choice especially in VMS Social Media… HCP 15% medicate Di
Slide 19: Imperative to invest competitively on Consumer, HCP & Store reach
Imperative to invest competitively on Consumer , HCP & Store reach Media Spends HCP Coverage Direct Store Coverage x x x < 0.1 x ~0.3-0.5 x ~0.4 x Top Spender SCHIL Peers SCHIL Peers SCHIL Benchmarked against top spender in category* Source : BARC, Industry sources, Proprietary Research, Media Spend
Slide 20: Agenda: Our Strategy
Agenda Journey since inception Road Ahead Our Strategy 19
Slide 21: Our Strategy
Our Strategy Synergistic demand generation through HCP & Self Choice – A true FMCH model MISSION Health. In your hands. By making selfcare as simple as it should be. VISION Become the best FMCH In & For India OUR STRATEGY Scale HCP Scale Consumer Improve Initiation. Engagement. Access. MAKING IT HAP
Slide 22: Scale HCP Engagement: Face to Face on Digital
Scale HCP Engagement Scale up HCP recommendations 2X Doctor reach Face to Face +50K Doctor reach on DIGITAL Includes AI-generated images
Slide 23: Step up Consumer Engagement: ~60 Mn multi-media reach
Step up Consumer Digital-first demand generation Engagement ~60 Mn multi-media reach* Targeted spends on Social to drive influence ~30% Includes AI-generated images *Includes multimedia reach
Slide 24: Improve Access: Win at store
Improve Increasing direct retail coverage & chemist recommendation Access Win at store 2X direct coverage
Slide 25: Right Talent & Culture to fuel profitable growth
Make it happen Right Talent & Culture to fuel profitable growth COMMERCIAL PRODUCTIVITY CULTURE ENGINE FMCH talent AI &Automation Challenger across: to : mindset: • Frontline • Free up capacity • Speed & • Brand • Strengthen Accountability • Alternate decision making • Differentiated channels at las
Slide 26: Leveraging digital & AI for superior, agile execution
Make it happen Leveraging digital & AI for superior, agile execution One Touch Data at fingertips – AI enabled prescriptive analysis AI-enabled agile visuals to bring to drive data-based decisions alive our brand superiority. Includes AI-generated images
Slide 27: Empowered Country Management
Make it happen Empowered Country Management India –first approach to innovations for Global brands too Complete ownership of Global Brand P&L Faster decision making & execution Dedicated in house ai creative team for India Benefit from Opella’s Global Scale, R&D & technology
Slide 28: Thank you
Thank you
Sanofi Consumer Healthcare India — Investor Presentation (March 2026) on 6ix